Innovation Pharmaceuticals Inc (IPIX)

[thekidzcollegephund]

From the White house link page 19

2. Anti-microbial resistant (AR) pathogens, including bacteria and fungi: CDC’s analysis, COVID-19:
U.S. Impact on Antimicrobial Resistance, Special Report 2022, demonstrated significant surges in
antibiotic use and AR infections during the first year of the pandemic in U.S. hospitals, including a
15% increase in both resistant hospital-onset infections and deaths. Prevention strategies—such as
antibiotic stewardship and infection prevention and control activities—remain the first line of
defense to stop the emergence and spread of AR, while simultaneously helping prepare for
unknown emerging threats in the future. Additionally, improved surveillance and reporting,
accurate and rapid diagnostic tests, and accelerated product development for new vaccines,
therapeutics, antibiotics and antifungals are all critical needs to address AR.